WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹14 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹-32 Cr |
| Mar2022 | ₹-29 Cr |
| Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 85.50 | |
| Mar2024 | ₹14 Cr | Positive | |
| Mar2023 | ₹-32 Cr | Negative | |
| Mar2022 | ₹-29 Cr | Negative | |
| Mar2021 | ₹-17 Cr | - | |
Compare Cash Flow from Financing Activities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹618.4 Cr | -16.1% | -25% | -22.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -16.1% |
-25% |
-22.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses